NCT00283634View on ClinicalTrials.gov

A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

August 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

August 31, 2007

Conditions
NSCLC
Interventions
DRUG

erlotinib and bortezomib

Trial Locations (1)

37920

University of Tennesee, Knoxville

Sponsors
All Listed Sponsors
collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

lead

Millennium Pharmaceuticals, Inc.

INDUSTRY